IP Library Granted Patent US 8,480,620
Granted Patent B2
US 8,480,620 · App. 12/636,124 · Granted Jul 9, 2013

Coatings with tunable solubility profile for drug-coated balloon

Inventors: John Stankus (Campbell, CA); Mikael Trollsas (San Jose, CA); Syed Hossainy (Hayward, CA)
Assignee: Abbott Cardiovascular Systems Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,480,620
App. No.
12/636,124
Granted
Jul 9, 2013
Kind
B2
Abstract

A drug delivery balloon is provided, the a balloon having an outer surface, and a tunable coating disposed on at least a length of the balloon surface. The tunable coating includes a first therapeutic agent and a first excipient, and a second therapeutic agent and a second excipient. The first and second therapeutic agents have different dissolution rates during balloon inflation and therefore provide a coating that is tunable.

Claims (12)

1. A balloon for delivery of a drug, the balloon comprising

a body having an outer surface; and

a coating disposed on at least a length of the outer surface, the coating including zotarolimus and at least one excipient, wherein the zotarolimus to excipient weight ratio is from about 20:1 to about 1:20, wherein the at least one excipient includes polyvinylpyrrolidone, and further wherein the at least one excipient increases the solubility of the zotarolimus to between 4 μg/ml to 1437 μg/ml.

2. The balloon of claim 1 , wherein the zotarolimus to excipient weight ratio is from about 2:1 to about 1:2.

3. The balloon of claim 1 , wherein the coating further includes a plasticizer.

4. The balloon of claim 3 , wherein the excipient to plasticizer weight ratio is from about 20:1 to about 1:20.

5. The balloon of claim 4 , wherein the excipient to plasticizer weight ratio is from about 10:1 to about 1:1.

6. The balloon of claim 3 , wherein the plasticizer is glycerol.

7. The balloon of claim 1 , wherein the at least one excipient includes a blend of polyvinylpyrrolidone having two different average molecular weights.

8. The balloon of claim 1 , wherein the at least one excipient is blended with a contrast agent.

9. The balloon of claim 1 , wherein the at least one excipient includes a polymer having a molecular weight of less than about 35 kDalton.

10. The balloon of claim 1 , further comprising a second excipient, wherein the second excipient is a polymer having a molecular weight greater than about 100 kDalton.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2010
From: STANKUS, JOHN; TROLLSAS, MIKAEL; HOSSAINY, SYED
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 024041/0804 →
Continuity (1)
Related Publication 20110144582A1 · Jun 16, 2011